Newsroom

Michelle Adams is the founder and president of Marketing Brainology, a consulting practice focused on translating consumer and shopper insights to corporate America, including findings from virtual shopping, behavioral science, and Neuroscience.

John Hixson, MD is an Associate Professor of Neurology at the University of California San Francisco and the San Francisco VA. Dr. Hixson’s primary clinical focus is treating epilepsy patients, while his primary research interests are to explore the use of mobile health applications in chronic neurologic disease. Dr. Hixson discusses the key issues surrounding portable EEG and MemoryMD’s NeuroEEG and NeuroCap devices, specifically.

John N. Gaitanis, MD is a pediatric neurologist and MemoryMD Medical Advisory Board member. After thoroughly examining the devices, Dr. Gaitanis provided his impressions of MemoryMD’s NeuroEEG and NeuroCap devices.

New York and Palo Alto, California-based MemoryMD have recently received FDA clearance for a disposable 19-channel EEG headset, called the NeuroCap. Along with the NeuroEEG, a wireless amplifier worn around the arm that transmits to computers via Bluetooth that was approved in February, the company is now preparing to launch its full offering as a convenient approach to EEG testing for clinicians treating patients at the point of care.

New York and Palo Alto, California-based MemoryMD has received FDA clearance for NeuroEEG, a wireless amplifier that transmits EEG signals to computers via Bluetooth. "Essentially we’ve innovated on existing EEG solutions in the market," MemoryMD Chief Quality Officer Abdus-Salaam Muwwakkil told MobiHealthNews.

MemoryMD presents innovative brain health solutions at Brain Trust.

MemoryMD, a technology firm, combines its expertise in brain analysis and artificial intelligence to offer innovative brain health solutions. The company is a pioneering neuro health data aggregator participating at Brain Trust, an annual summit hosted by the U.S. Department of Veterans Affairs Center for Innovation (VACI). This will be a two-day event promoting public-private partnerships to address significant health challenges facing the veteran community. The applicability of their solutions for better detection and management of veteran health has allowed MemoryMD to fulfill Brain Trust's evaluation criteria.